Clinical Evaluation of T.R.U.E. TEST Panel 3.2 in Children and Adolescents

PHASE3WithdrawnINTERVENTIONAL
0
Timeline

Start Date

December 31, 2012

Primary Completion Date

December 31, 2013

Study Completion Date

December 31, 2013

Conditions
Contact Dermatitis
Interventions
BIOLOGICAL

Patch Test

Patch Tested with Gold sodium thiosulfate, 0.075 mg/cm2 in hydroxypropylcellulose · Hydrocortisone-17-butyrate, 0.020 mg/cm2 in polyvinylpyrrolidone· Methyldibromoglutaronitrile, 0.0053 mg/cm2 in polyvinylpyrrolidone·Bacitracin, 0.60 mg/cm2 in hydroxypropylcellulose· Parthenolide, 0.0030 mg/cm2 in polyvinylpyrrolidone· Disperse blue 106, 0.050 mg/cm2 in polyvinylpyrrolidone· Bronopol, 0.25 mg/cm2 in polyvinylpyrrolidone

Trial Locations (2)

40202

Dermatology Specialists, Louisville

80045

Anschutz Health and Wellness Center, University of Colorado, Aurora

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Allerderm

INDUSTRY

NCT01518348 - Clinical Evaluation of T.R.U.E. TEST Panel 3.2 in Children and Adolescents | Biotech Hunter | Biotech Hunter